Retina

Here, we recognize a year’s worth of innovation. Apps, IOLs, imagers, lasers, devices and drugs – the latest and greatest are all here. But which one came out on top this year?

Placental growth factor inhibitors might show efficacy in treating dry AMD as well as wet. Might aflibercept be repurposed?

Big data EMR mining (and some basic research) identifies a 50-year old drug that appears to protect against AMD development

A new tissue culture model of the retinal pigment epithelium may allow researchers to better understand the impacts of new interventions on the adult human retina

Celebrating its 25th anniversary at the American Academy of Ophthalmology (AAO) Meeting in Las Vegas, Heidelberg Engineering will present its latest diagnostic imaging technologies and services. For a quarter of a century, the company has been committed to delivering solutions to fundamental clinical needs in ophthalmology.

Leading Ophthalmologists from Three Countries Present Real World Clinical Outcomes on Oraya Therapy for Wet AMD

Optogenetics holds the potential of reversing blindness in retinal disease – but how far has the field come, and who are the key players?

A patient has undergone a premium refractive cataract procedure, and they’re unhappy. How are you going to fix it?

Vaccination complications as an explanation for retinal hemorrhage in children should not be accepted clinically or legally, new study data suggests

Vasotide, a small molecule that stops VEGF binding to endothelial receptor molecules, has shown promise in animal models and can be delivered using eyedrops